Barrett & Company’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.1K Buy
285
+50
+21% +$7.05K 0.01% 335
2026
Q2
$34.4K Buy
235
+100
+74% +$18.1K 0.01% 357
2026
Q1
$19.9K Hold
135
– – 0.01% 401
2025
Q4
$26.3K Hold
135
– – 0.01% 371
2025
Q3
$38K Hold
135
– – 0.01% 330
2025
Q2
$29.5K Hold
135
– – 0.01% 366
2025
Q1
$18.9K Hold
135
– – 0.01% 382
2024
Q4
$22.5K Hold
135
– – 0.01% 360
2024
Q3
$23K Sell
135
-60
-31% -$8.69K 0.01% 347
2024
Q2
$27.5K Hold
195
– – 0.01% 341
2024
Q1
$24.5K Hold
195
– – 0.01% 350
2023
Q4
$20.6K Hold
195
– – 0.01% 342
2023
Q3
$20.7K Hold
195
– – 0.01% 337
2023
Q2
$23.2K Hold
195
– – 0.01% 332
2023
Q1
$18.1K Hold
195
– – 0.01% 335
2022
Q4
$15.9K Hold
195
– – 0.01% 339
2022
Q3
$15.9K Buy
+195
New +$14.3K 0.01% 339

Other funds holding ORCL

Barrett & Company's ORCL Position: Q3 2026 in Review

Barrett & Company increased its Oracle (ORCL) stake by 21% in Q3 2026, buying an estimated $7.05K and bringing the position to 285 shares worth $39.1K. The position accounts for 0.01% of the portfolio, ranked #335.

Barrett & Company first reported a position in ORCL in Q3 2022 and has held it in 17 quarters since. 1,682 funds tracked by Wall St. Rank hold ORCL as of Q3 2026.

  • Barrett & Company held 285 shares of Oracle worth $39.1K as of Q3 2026.
  • Barrett & Company bought 50 Oracle shares in Q3 2026, an estimated $7.05K.
  • Oracle made up 0.01% of Barrett & Company's portfolio in Q3 2026, its #335 holding.
  • Barrett & Company first reported a position in Oracle in Q3 2022 and has held it in 17 quarters since.
  • 1,682 funds tracked by Wall St. Rank held Oracle as of Q3 2026.

Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.